comparemela.com

Latest Breaking News On - Branded pharmaceuticals - Page 10 : comparemela.com

Endo International plc: ENDO REPORTS FOURTH-QUARTER AND FULL-YEAR 2021 FINANCIAL RESULTS

DUBLIN, Feb. 28, 2022 /PRNewswire/ Endo International plc (NASDAQ: ENDP) today reported financial results for the fourth-quarter and full-year ended December 31, 2021 and introduced first-quarter

New yorkUnited statesChestnut ridgeBlaise colemanPrnewswire endo internationalCompany netBranded pharmaceuticalsCompany net debt leverage ratioGeneric pharmaceuticalsEndo investor relations departmentExchange commissionInternational pharmaceuticalsPfizer incEndo internationalCompany lossChief executive officer

ENDO REPORTS FOURTH-QUARTER AND FULL-YEAR 2021 FINANCIAL RESULTS

Press release content from PR Newswire. The AP news staff was not involved in its creation.

New yorkUnited statesChestnut ridgeBlaise colemanPrnewswire endo internationalCompany netBranded pharmaceuticalsCompany net debt leverage ratioGeneric pharmaceuticalsEndo investor relations departmentExchange commissionInternational pharmaceuticalsPfizer incEndo internationalCompany lossChief executive officer

Endo International Plc (ENDP) Q3 2021 Earnings Call Transcript

ENDP earnings call for the period ending September 30, 2021.

New yorkUnited statesPatrick barryBlaise colemanGary nachmanPiper sandlerBalaji prasad barclaysAnnabel samimyAnnabel samimy stifelBalaji prasadMark bradleyDavid amsellemDavid amsellem piper sandlerEndo international plcBranded pharmaceuticalsPsexual medicine society of north america

Endo Reports Third-Quarter 2021 Financial Results And Raises 2021 Financial Guidance

/PRNewswire/ Endo International plc (NASDAQ: ENDP) today reported financial results for the third-quarter ended September 30, 2021. "We delivered strong.

Blaise colemanCompany netBranded pharmaceuticalsCompany net debt leverage ratioGeneric pharmaceuticalsEndo investor relations departmentExchange commissionInternational pharmaceuticalsPfizer incEndo internationalStrides pharma scienceCompany lossChief executive officerMonths ended septemberDiluted netContinuing operations

Endo International plc: Endo Reports Third-Quarter 2021 Financial Results And Raises 2021 Financial Guidance

DUBLIN, Nov. 4, 2021 /PRNewswire/ Endo International plc (NASDAQ: ENDP) today reported financial results for the third-quarter ended September 30, 2021. "We delivered strong third-quarter

Blaise colemanPrnewswire endo internationalCompany netBranded pharmaceuticalsCompany net debt leverage ratioGeneric pharmaceuticalsEndo investor relations departmentExchange commissionInternational pharmaceuticalsPfizer incEndo internationalStrides pharma scienceCompany lossChief executive officerMonths ended septemberDiluted net

vimarsana © 2020. All Rights Reserved.